Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism AMHR2 modulators(Anti-Mullerian hormone receptor II modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Cambrian BioPharma, Inc.Startup |
Active Organization Cambrian BioPharma, Inc.StartupOviva Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Diseases | Preclinical | US | Oviva Therapeutics, Inc.Startup | 07 Aug 2023 |
Ovarian Diseases | Preclinical | US | Cambrian BioPharma, Inc.Startup | 07 Aug 2023 |